Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 11-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,982 | 9,332 | 11,903 | 16,400 | 21,335 |
| Receivables | N/A | N/A | 2,000 | 2,000 | 2,000 |
| TOTAL | $8,839 | $13,350 | $17,878 | $20,984 | $24,633 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 96 | 133 | 169 | 207 | 244 |
| TOTAL | $96 | $133 | $169 | $207 | $244 |
| Total Assets | $8,935 | $13,483 | $18,047 | $21,191 | $24,877 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,245 | 14,175 | 14,692 | 15,127 | 14,244 |
| Accrued Expenses | 43,667 | 28,042 | 28,626 | 28,297 | 27,852 |
| TOTAL | $85,112 | $69,417 | $70,518 | $70,565 | $70,627 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 43,571 | 43,571 | 43,571 | 43,605 | 43,640 |
| TOTAL | $43,571 | $43,571 | $43,571 | $43,605 | $43,640 |
| Total Liabilities | $128,683 | $112,988 | $114,089 | $114,170 | $114,267 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,270,395 | 1,259,753 | 1,251,534 | 1,232,433 | 1,228,232 |
| Common Shares | 1,266 | 1,257 | 1,249 | 1,233 | 1,224 |
| Retained earnings | -915,933 | -893,326 | -887,786 | -881,830 | -877,072 |
| TOTAL | $-119,748 | $-99,505 | $-96,042 | $-92,979 | $-89,390 |
| Total Liabilities And Equity | $8,935 | $13,483 | $18,047 | $21,191 | $24,877 |